INTRODUCTION: Chronic Recurrent Multifocal Osteomyelitis (CRMO) is an autoinflammatory bone disorder with predominantly paediatric onset. Children present with multifocal osteolytic lesions accompanied by bone pain and soft tissue swelling. Patients often exhibit extraosseous co-morbidities such as psoriasis, inflammatory bowel disease, and arthritis. OBJECTIVES: Comparison of children with two different phenotypes of CRMO defined by presence or absence of extraosseous co-morbidities. METHODS: Children diagnosed with CRMO at the Motol University Hospital between 2010 and 2020 were retrospectively reviewed, and according to the absence or presence of extraosseous manifestations divided into two cohorts - bone limited CRMO and complex CRMO. The two groups were compared in terms of demographic data, age at disease onset, number and site of bone lesions, laboratory biomarker values, and need of escalation to a second-line therapy. RESULTS: Thirty-seven children (30 female, 7 male) with confirmed CRMO were included in the analysis. The mean age at disease onset was 10 years. All but 3 patients presented with multifocal disease. Twenty-three children (62%) had at least one extraosseous manifestation (13 sacroiliitis, 8 inflammatory bowel disease, 6 skin disease [acne, pustulosis, or psoriasis], 7 arthritis). Complex CRMO was associated with a significantly higher ESR rate (p = 0.0064) and CRP level (p = 0.018). The groups did not differ in number of foci or in age at disease onset. Bone lesion distribution differed between the two groups with significantly more frequent involvement of clavicle (p = 0.011) and pelvis (p = 0.038) in patients with complex CRMO. Children with complex CRMO more often needed escalation of therapy to DMARDs and biologic agents. CONCLUSION: Our data suggest that CRMO affecting solely the skeleton has milder course compared to complex CRMO with extraskeletal features. Further studies are needed to explore the clinical as well as the patient reported outcomes and promote individually tailored therapeutic strategies in both CRMO phenotypes.

Department of Biophysical Chemistry J Heyrovsky Institute of Physical Chemistry of the Czech Academy of Sciences Prague Czech Republic

Department of Ortopaedics 2nd Faculty of Medicine Motol University Hospital Prague Czech Republic

Department of Paediatric and Adult Rheumatology Motol University Hospital Prague Czech Republic

Department of Pediatrics 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Department of Radiology 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Zobrazit více v PubMed

Bjorksten B, Gustavson KH, Eriksson B, Lindholm A, Nordstrom S. Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr. 1978;93:227–231. doi: 10.1016/S0022-3476(78)80501-0. PubMed DOI

Giedion A. Subacute and chronic "symmetrical" osteomyeliti. Ann Radiol (Paris) 1972;15:329–342. PubMed

Jansson AF, Grote V, Group, E.S Nonbacterial osteitis in children: data of a German Incidence Surveillance Study. Acta Paediatr. 2011;100:1150–1157. doi: 10.1111/j.1651-2227.2011.02205.x. PubMed DOI

Andronikou S, et al. Whole-body MRI in the diagnosis of paediatric CNO/CRMO. Rheumatology (Oxford) 2020;59:2671–2680. doi: 10.1093/rheumatology/keaa303. PubMed DOI

Zhao Y, Ferguson PJ. Chronic Nonbacterial Osteomyelitis and Chronic Recurrent Multifocal Osteomyelitis in Children. Pediatr Clin North Am. 2018;65:783–800. doi: 10.1016/j.pcl.2018.04.003. PubMed DOI

Borzutzky A, et al. Pediatric chronic nonbacterial osteomyelitis. Pediatrics. 2012;130:e1190–e1197. doi: 10.1542/peds.2011-3788. PubMed DOI

Wipff J, et al. A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol. 2015;67:1128–1137. doi: 10.1002/art.39013. PubMed DOI

O'Leary D, Wilson AG, MacDermott EJ, Lowry C, Killeen OG. Variability in phenotype and response to treatment in chronic nonbacterial osteomyelitis; the Irish experience of a national cohort. Pediatr Rheumatol Online J. 2021;19:45. doi: 10.1186/s12969-021-00530-4. PubMed DOI PMC

Girschick H, et al. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology (Oxford) 2018;57:1203–1211. doi: 10.1093/rheumatology/key058. PubMed DOI

Zhao Y, et al. Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions. Arthritis Care Res (Hoboken) 2018;70:1228–1237. doi: 10.1002/acr.23462. PubMed DOI PMC

Cox AJ, et al. Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO) PLoS One. 2017;12:e0169687. doi: 10.1371/journal.pone.0169687. PubMed DOI PMC

d'Adamo AP, et al. High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO) Pediatr Rheumatol Online J. 2020;18:55. doi: 10.1186/s12969-020-00447-4. PubMed DOI PMC

Ferguson PJ, et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome) J Med Genet. 2005;42:551–557. doi: 10.1136/jmg.2005.030759. PubMed DOI PMC

Aksentijevich I, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med. 2009;360:2426–2437. doi: 10.1056/NEJMoa0807865. PubMed DOI PMC

Vittecoq O, et al. Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum. 2000;43:109–119. doi: 10.1002/1529-0131(200001)43:1<109::AID-ANR14>3.0.CO;2-3. PubMed DOI

Jansson A, et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 2007;46:154–160. doi: 10.1093/rheumatology/kel190. PubMed DOI

Beck C, et al. Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther. 2010;12:R74. doi: 10.1186/ar2992. PubMed DOI PMC

Kostik MM, Kopchak OL, Chikova IA, Isupova EA, Mushkin AY. Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis. Rheumatol Int. 2019;39:89–96. doi: 10.1007/s00296-018-4151-9. PubMed DOI

Schnabel A, Range U, Hahn G, Berner R, Hedrich CM. Treatment Response and Longterm Outcomes in Children with Chronic Nonbacterial Osteomyelitis. J Rheumatol. 2017;44:1058–1065. doi: 10.3899/jrheum.161255. PubMed DOI

Dushnicky MJ, et al. Pediatric Patients with a Dual Diagnosis of Inflammatory Bowel Disease and Chronic Recurrent Multifocal Osteomyelitis. J Pediatr Gastroenterol Nutr. 2021;73:626–629. doi: 10.1097/MPG.0000000000003225. PubMed DOI

Sag E, et al. Chronic recurrent multifocal osteomyelitis in children: a single center experience over five years. Turk J Pediatr. 2019;61:386–391. doi: 10.24953/turkjped.2019.03.010. PubMed DOI

Roderick MR, Shah R, Rogers V, Finn A, Ramanan AV. Chronic recurrent multifocal osteomyelitis (CRMO) - advancing the diagnosis. Pediatr Rheumatol Online J. 2016;14:47. doi: 10.1186/s12969-016-0109-1. PubMed DOI PMC

Chamot AM, et al. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic. 1987;54:187–196. PubMed

Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol. 1995;7:263–269. doi: 10.1097/00002281-199507000-00001. PubMed DOI

Gracey E, et al. Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis. Nat Rev Rheumatol. 2020;16:415–433. doi: 10.1038/s41584-020-0454-9. PubMed DOI

Myers B, et al. The gut microbiome in psoriasis and psoriatic arthritis. Best Pract Res Clin Rheumatol. 2019;33:101494. doi: 10.1016/j.berh.2020.101494. PubMed DOI

Verwoerd A, Ter Haar NM, de Roock S, Vastert SJ, Bogaert D. The human microbiome and juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14:55. doi: 10.1186/s12969-016-0114-4. PubMed DOI PMC

Cantarelli E, Baccelli F, Simonini G, Alvisi P. Chronic recurrent multifocal osteomyelitis associated with crohn disease: a potential role of exclusion diet? comment on starz et al. The modification of the gut microbiota via selected specific diets in patients with crohn's disease. Nutrients 2021, 13, 2125. Nutrients. 2021;13:4005. doi: 10.3390/nu13114005. PubMed DOI PMC

Akkoc N, Yarkan H, Kenar G, Khan MA. Ankylosing Spondylitis: HLA-B*27-Positive Versus HLA-B*27-Negative Disease. Curr Rheumatol Rep. 2017;19:26. doi: 10.1007/s11926-017-0654-8. PubMed DOI

Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol. 2006;20:451–471. doi: 10.1016/j.berh.2006.03.010. PubMed DOI

Mielants H, Veys EM, Cuvelier C, De Vos M. Subclinical involvement of the gut in undifferentiated spondylarthropathies. Clin Exp Rheumatol. 1989;7:499–504. PubMed

Brown MA, Kenna T, Wordsworth BP. Genetics of ankylosing spondylitis--insights into pathogenesis. Nat Rev Rheumatol. 2016;12:81–91. doi: 10.1038/nrrheum.2015.133. PubMed DOI

Barthel D, et al. Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics. J Rheumatol. 2015;42:2160–2165. doi: 10.3899/jrheum.140472. PubMed DOI

Pugliese D, et al. Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study. Aliment Pharmacol Ther. 2015;42:880–888. doi: 10.1111/apt.13352. PubMed DOI

Rosenwasser N, Lee D, Sidbury R, Zhao Y. Paradoxical Psoriasis in Children Receiving Anti-TNFalpha Treatment for Inflammatory/autoimmune Disease. Paediatr Drugs. 2021;23:131–141. doi: 10.1007/s40272-021-00440-8. PubMed DOI

Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377:2138–2149. doi: 10.1016/S0140-6736(11)60244-4. PubMed DOI

Thatayatikom A, Modica R, De Leucio A. Juvenile Idiopathic Arthritis. Treasure Island: StatPearls; 2022. PubMed